Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND/AIMS: A strong association exists between ulcerative colitis and primary sclerosing cholangitis (PSC). Previously, the presence of a unique epitope shared by colon and biliary epithelial cells was shown by using the novel monoclonal antibody (MAb) 7E12H12 developed against a colonic epithelial protein. In the present study, the presence of circulating autoantibody in PSC against this peptide was examined. METHODS: Sera from 16 patients with PSC, 13 with primary biliary cirrhosis, 6 with secondary biliary stricture, and 6 with chronic liver diseases and 10 normal subjects were used. An inhibition immunoperoxidase assay using the 7E12H12 MAb was developed against sections of bile duct and gallbladder. Sera were also examined in an enzyme-linked immunosorbent assay (ELISA) against the gallbladder extract enriched in 7E12H12-reactive protein. RESULTS: About two thirds of the sera from patients with PSC blocked the binding of 7E12H12 MAb on the bile duct and gallbladder, whereas non-PSC sera did not. In the ELISA, 93% of PSC sera had circulating immunoglobulin G antibodies against the enriched gallbladder extract. The reactivity of sera from the PSC group was significantly (P < 0.01 to P < 0.0001) higher than in each of the non-PSC groups. CONCLUSIONS: Sera from patients with PSC contains autoantibodies against a cross-reactive peptide shared by colon and biliary epithelial cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ursodiol for Primary Sclerosing Cholangitis
Lindor, K. D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361003 · Cited by 598
Primary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. H. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 592
Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease
Navaneethan, U., & Shen, B. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21219 · Cited by 201
“PSC was not reported to be associated with any disease-specific autoantibodies, and the disease has not responded well to traditional immunosuppressive therapy.44,45 Microbiological mechanisms may provide additional clues for the link between PSC and IBD.”
BackgroundInfluentialAutoantibodies in primary sclerosing cholangitis
Hov, J. R., Boberg, K. M., & Karlsen, T. H. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3781 · Cited by 187
Malignancies of the biliary tree
Pitt, H. A., Yeo, C. J., Dooley, W. C., & Cameron, J. L. (1995) · Current Problems in Surgery · doi:10.1016/s0011-3840(05)80011-5 · Cited by 171
Metadata
- Authors
- Mandal, A., Dasgupta, A., Jeffers, L., Squillante, L., Hyder, S., Reddy, R., Schiff, E., & Das, K. M.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 1994-01
- Volume
- 106
- Issue
- 1
- Pages
- 185-192
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1910841180
- Cited by
- 92
- References
- 0
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium. https://app.cochat.ai/papers/10.1016/s0016-5085(94)95271-x
- The paper
- Mandal, A., Dasgupta, A., Jeffers, L., Squillante, L., Hyder, S., Reddy, R., Schiff, E., & Das, K. M. (1994). Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium. Gastroenterology. https://doi.org/10.1016/s0016-5085(94)95271-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.